A profile on the CardioMEMS HF system in the management of patients with early stages of heart failure: an update

ABSTRACT Introduction Over the past decade, there have been noteworthy advances in the evaluation and treatment of heart failure (HF). Despite an improved understanding of this chronic disease, HF is still one of the leading causes of morbidity and mortality in the United States and worldwide. Decompensation and rehospitalization of HF patients remain an integral problem in disease management, with significant economic implications. Remote monitoring systems have been developed to detect HF decompensation early and address it before hospitalization. The CardioMEMS HF system is a wireless pulmonary artery (PA) monitoring system that detects changes in PA pressure and transmits data to the healthcare provider. As changes in PA pressures occur early during HF decompensation, the CardioMEMS HF system allows providers to institute timely changes in HF medical therapies to alter the course of the decompensation. The use of the CardioMEMS HF system has been shown to reduce HF hospitalization and improve quality of life. Areas Covered This review will focus on the available data supporting the expanded utilization of the CardioMEMS system in patients with HF. Expert Opinion The CardioMEMS HF system is a relatively safe and cost-effective device that reduces the incidence of HF hospitalization and qualifies as intermediate-to-high value medical care.

[1]  Akshay S. Desai,et al.  Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring. , 2022, Journal of cardiac failure.

[2]  Akshay S. Desai,et al.  Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial. , 2022, JACC. Heart failure.

[3]  B. Assmus,et al.  Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial , 2022, ESC heart failure.

[4]  Dave L Dixon,et al.  2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. , 2022, Journal of cardiac failure.

[5]  F. Crea,et al.  The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients with Heart Failure: Remote Left Atrial Pressure Monitoring. , 2022, Journal of cardiac failure.

[6]  Akshay S. Desai,et al.  Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial , 2021, The Lancet.

[7]  S. Pedersen,et al.  Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  Akshay S. Desai,et al.  Response by Shavelle et al to Letters Regarding Article, "Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study". , 2021, Circulation. Heart failure.

[9]  J. Brachmann,et al.  Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS‐HF) , 2020, European journal of heart failure.

[10]  G. Moukarbel,et al.  CardioMEMSTM System in the Daily Management of Heart Failure: Review of Current Data and Technique of Implantation , 2020, Expert review of medical devices.

[11]  W. Wijns,et al.  Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first‐in‐human study , 2020, European journal of heart failure.

[12]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.

[13]  J. Denollet,et al.  Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  L. Klein,et al.  Internal Jugular Vein as Alternative Access for Implantation of a Wireless Pulmonary Artery Pressure Sensor. , 2019, Circulation. Heart failure.

[15]  Sinan Sarsam,et al.  CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: A single center experience , 2019, JRSM cardiovascular disease.

[16]  Nir Uriel,et al.  Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring , 2018, ESC heart failure.

[17]  Z. Khan,et al.  Validating Left Ventricular Filling Pressure Measurements in Patients with Congestive Heart Failure: CardioMEMS™ Pulmonary Arterial Diastolic Pressure versus Left Atrial Pressure Measurement by Transthoracic Echocardiography , 2018, Cardiology research and practice.

[18]  Sinan Sarsam,et al.  Impact of CardioMEMS device placement on lifestyle modifications: a “pseudo-placebo” effect beyond the expected? , 2018, The Journal of international medical research.

[19]  G. Moukarbel,et al.  Patient Factors But Not the Use of Novel Anticoagulants or Warfarin Are Associated With Internal Jugular Vein Access-Site Hematoma After Right Heart Catheterization. , 2017, The Journal of invasive cardiology.

[20]  M. Vaduganathan,et al.  Postmarketing Adverse Events Related to the CardioMEMS HF System , 2017, JAMA cardiology.

[21]  L. Stevenson,et al.  Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction. , 2017, Journal of the American College of Cardiology.

[22]  L. Klein (Re)Discovering the Neurohormonal and Hemodynamic Duality of Heart Failure. , 2017, Journal of the American College of Cardiology.

[23]  D. Feldman,et al.  The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory Support , 2017, ASAIO journal.

[24]  L. Hűbbert,et al.  Left Atrial Pressure Monitoring With an Implantable Wireless Pressure Sensor After Implantation of a Left Ventricular Assist Device , 2017, ASAIO journal.

[25]  J. Morgan,et al.  Remote management of heart failure using implantable electronic devices , 2017, European heart journal.

[26]  Akshay S. Desai,et al.  Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice. , 2017, Journal of the American College of Cardiology.

[27]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of cardiac failure.

[28]  Michael Illovsky,et al.  Ambulatory Heart Failure Monitoring: A Systemic Review , 2017, Cureus.

[29]  R. Jermyn,et al.  Hemodynamic‐guided heart‐failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease‐management program , 2017, Clinical cardiology.

[30]  William T. Abraham,et al.  Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor , 2017, Circulation.

[31]  W. Aronow,et al.  Ambulatory pulmonary artery pressure monitoring in advanced heart failure patients , 2017, World journal of cardiology.

[32]  Akshay S. Desai,et al.  Pulmonary Artery Pressure–Guided Heart Failure Management Reduces 30-Day Readmissions , 2016, Circulation. Heart failure.

[33]  Michael Böhm,et al.  Fluid status telemedicine alerts for heart failure: a randomized controlled trial. , 2016, European heart journal.

[34]  L. Stevenson,et al.  Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial , 2016, The Lancet.

[35]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[36]  Jagmeet P. Singh,et al.  Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF). , 2015, Journal of cardiac failure.

[37]  R. Benza,et al.  Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease: insights from a wireless pulmonary artery pressure monitoring system. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[38]  R. Benza,et al.  Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[39]  William T. Abraham,et al.  Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction , 2014, Circulation. Heart failure.

[40]  G. Hindricks,et al.  Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.

[41]  Naoki Sato,et al.  The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.

[42]  M. Guglin,et al.  Patient selection for ventricular assist devices: a moving target. , 2013, Journal of the American College of Cardiology.

[43]  M. Gheorghiade,et al.  The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy. , 2012, Journal of cardiac failure.

[44]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[45]  D. Mancini,et al.  Selection of Cardiac Transplantation Candidates in 2010 , 2010, Circulation.

[46]  William T. Abraham,et al.  Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.

[47]  P. Adamson,et al.  Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices , 2009, Current heart failure reports.

[48]  G. Navis,et al.  Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.

[49]  M. Zile,et al.  Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.

[50]  R. Bourge,et al.  Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. , 2007, Journal of the American College of Cardiology.

[51]  Javed Butler,et al.  Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. , 2007, Journal of the American College of Cardiology.

[52]  Z. Jing,et al.  Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. , 2006, Journal of the American College of Cardiology.

[53]  Monica R. Shah,et al.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .

[54]  R. Hershberger,et al.  Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. , 2003, Journal of cardiac failure.

[55]  M. Zile,et al.  Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor: Relationship to Mortality in Patients With Chronic Heart Failure. , 2017, Circulation. Heart failure.

[56]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[57]  G. Fonarow,et al.  The Prevention of Hospital Readmissions in Heart Failure. , 2016, Progress in cardiovascular diseases.